HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wheelan, P. Articles by Murphy, R. C. Search for Related Content PubMed PubMed Citation Articles by Wheelan, P. Articles by Murphy, R. C. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 268, Issue 34, 25439-25448, 12, 1993

Metabolism of leukotriene B4 by cultured human keratinocytes. Formation of glutathione conjugates and dihydro metabolites

P Wheelan, JA Zirrolli, JG Morelli and RC Murphy
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.

Six previously unidentified leukotriene (LT) B4 metabolites formed during incubation of LTB4 with human keratinocytes in primary culture indicate the importance of the 12-hydroxyeicosanoid dehydrogenase pathway in LTB4 metabolism. The ultraviolet absorption spectra obtained for all keratinocyte metabolites revealed the presence of a conjugated diene structural moiety rather than the conjugated triene structure of LTB4. Metabolites were characterized using fast atom bombardment-mass spectrometry, gas chromatography-mass spectrometry of the pentafluorobenzyl ester, trimethylsilyl ether derivatives and specific degradation reactions. The previously identified 10,11-dihydro-LTB4 and 10,11-dihydro-12-epi-LTB4 were observed as well as 20-OH-10,11-dihydro- LTB4, consistent with the reductase pathway of LTB4 metabolism. This pathway involves initial formation of 12-oxo-LTB4 catalyzed by 12- hydroxyeicosanoid dehydrogenase followed by reduction by delta 10- reductase. The most lipophilic metabolite of LTB4 was identified as 10- hydroxy-4,6,12-octadecatrienoic acid which could result from beta- oxidation reactions of LTB4 following reduction of the 10,11-double bond. One of the most abundant metabolites was characterized as 3,7,14- trihydroxy-8,10,16- docosatrienoic acid which could result from fatty acid elongation following reduction of the 10,11-double bond. Additional abundant LTB4 metabolites were identified that result from glutathione conjugation of 12-oxo-LTB4. These were characterized using fast atom bombardment-mass spectrometry and by chemical degradation using hypochlorous acid as well as transpeptidases. These metabolites were identified as 5,12-dihydroxy-6-glutathionyl-7,9,14-eicosatrienoic acid (c-LTB3), 5,12-dihydroxy-6-cysteinyl-glycyl-7,9,14-eicosatrienoic acid (d-LTB3) and 5,12-dihydroxy-6-cysteinyl-7,9,14-eicosatrienoic acid (e-LTB3). We propose that these metabolites result from a 1,8 Michael- type addition of glutathione to the 12-oxo-LTB4 intermediate.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Kalsotra, L. Du, Y. Wang, P. A. Ladd, Y. Kikuta, M. Duvic, A. S. Boyd, D. S. Keeney, and H. W. Strobel Inflammation resolved by retinoid X receptor-mediated inactivation of leukotriene signaling pathways FASEB J, February 1, 2008; 22(2): 538 - 547. [Abstract] [Full Text] [PDF]

				K. A. Z. Berry, P. Borgeat, J. Gosselin, L. Flamand, and R. C. Murphy Urinary Metabolites of Leukotriene B4 in the Human Subject J. Biol. Chem., June 27, 2003; 278(27): 24449 - 24460. [Abstract] [Full Text] [PDF]

				J. M. Hevko, R. C. Bowers, and R. C. Murphy Synthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid and Identification of Novel omega -Oxidized Metabolites in the Mouse Macrophage J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 293 - 305. [Abstract] [Full Text]

				J. A. HANKIN and R. C. MURPHY The Metabolism of Leukotriene B4 in Lewis Lung Carcinoma Porcine Kidney Cells Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S81 - 87. [Full Text] [PDF]

				P. Wheelan, J. A. Hankin, B. Bilir, D. Guenette, and R. C. Murphy Metabolic Transformations of Leukotriene B4 in Primary Cultures of Human Hepatocytes J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 326 - 334. [Abstract] [Full Text]

				T. Yokomizo, Y. Ogawa, N. Uozumi, K. Kume, T. Izumi, and T. Shimizu cDNA Cloning, Expression, and Mutagenesis Study of Leukotriene B(4) 12-Hydroxydehydrogenase J. Biol. Chem., February 2, 1996; 271(5): 2844 - 2850. [Abstract] [Full Text] [PDF]

				P. Wheelan and R. C. Murphy Metabolism of 6-trans-Isomers of Leukotriene B(4) in Cultured Hepatoma Cells and in Human Polymorphonuclear Leukocytes J. Biol. Chem., August 25, 1995; 270(34): 19845 - 19852. [Abstract] [Full Text] [PDF]